Gucy2c cart cell therapy (Innovative Cellular Therapeutics)

N/A

Report date: 2022/12/31 18:17:09

Base Information

Drug NameGucy2c cart cell therapy (Innovative Cellular Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsAnti-Heat-stable enterotoxin receptor
TargetsHeat-stable enterotoxin receptor
Therapy Area/IndicationsDigestive System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnovative Cellular Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnovative Cellular Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsDigestive System Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A